This brand name is authorized in Austria, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Turkey, United Kingdom, United States
The drug TRISENOX contains one active pharmaceutical ingredient (API):
|
1
Arsenic trioxide
UNII S7V92P67HO - ARSENIC TRIOXIDE
|
|
Arsenic trioxide causes morphological changes and deoxyribonucleic acid (DNA) fragmentation characteristic of apoptosis in NB4 human promyelocytic leukaemia cells in vitro. Arsenic trioxide also causes damage or degradation of the fusion protein PML/RAR alpha. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| TRISENOX Concentrate for solution for infusion | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| L01XX27 | Arsenic trioxide | L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XX Other antineoplastic agents |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 537518050007217 |
| Country: CA | Health Products and Food Branch | Identifier(s): 02407833, 02480387 |
| Country: EE | Ravimiamet | Identifier(s): 1202566, 1797699 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 102204002 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 499695 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 61128000 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 385915 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 035712013, 035712025 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 4291409A1026, 4291409A2022 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1031455, 1087929 |
| Country: NL | Z-Index G-Standaard | Identifier(s): 14750368 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 201979, 61522 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100131957, 100421030, 100427362 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W62932001, W65972001 |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699638764143 |
| Country: US | FDA, National Drug Code | Identifier(s): 63459-600, 63459-601 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
